Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours

No Featured Image set

Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours

20-04-2026

Birgit S. Geurts, Thomas W. Battaglia, J. Maxime Van Berge Henegouwen, Laurien J. Zeverijn, Gijs F. De Wit, Louisa R. …

No Featured Image set

Identifying somatic changes in drug transporters using whole genome and transcriptome sequencing data of advanced tumors

20-04-2026

Wesley S. Van De Geer, Ron H.J. Mathijssen, Job Van Riet, Neeltje Steeghs, Mariette Labots, Carla Van Herpen, Lot A. …

No Featured Image set

Pan-cancer whole-genome comparison of primary and metastatic solid tumours

20-04-2026

Francisco Martínez-Jiménez, Ali Movasati, Sascha Remy Brunner, Luan Nguyen, Peter Priestley, Edwin Cuppen & Arne Van Hoeck Nature, 2023, DOI

No Featured Image set

Genetic immune escape landscape in primary and metastatic cancer

20-04-2026

Francisco Martínez-Jiménez, Peter Priestley, Charles Shale, Jonathan Baber, Erik Rozemuller & Edwin Cuppen Nature Genetics, 2023, DOI

No Featured Image set

Heritable defects in telomere and mitotic function selectively predispose to sarcomas

20-04-2026

Mandy L. Ballinger, Swetansu Pattnaik, Piyushkumar A. Mundra, Milita Zaheed, Emma Rath, Peter Priestley, Jonathan Baber, Isabelle Ray-Coquard, Nicholas Isambert, …

No Featured Image set

Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice

20-04-2026

Kris G. Samsom, Linda J. W. Bosch, Luuk J. Schipper, Daoin Schout, Paul Roepman, Mirjam C. Boelens, Ferry Lalezari, Elisabeth …

No Featured Image set

Heritable defects in telomere and mitotic function selectively predispose to sarcomas

12-02-2026

Mandy L. Ballinger, Swetansu Pattnaik, Piyushkumar A. Mundra, Milita Zaheed, Emma Rath, Peter Priestley, Jonathan Baber, Isabelle Ray-Coquard, Nicholas Isambert, …

Terug naar het laatste nieuws

Wilt u op de hoogte blijven van nieuwe ontwikkelingen?

Abonneer u op onze nieuwsbrieven

Meer weten over de complete DNA-test?

Ga naar OncoAct.nl